Literature DB >> 24710679

[MAO-inhibitors--a treatment option for treatment resistant depression: application, efficacy and characteristics].

S Köhler1, L A Stöver1, T Bschor2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24710679     DOI: 10.1055/s-0034-1365945

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


× No keyword cloud information.
  3 in total

1.  [Tricyclic antidepressants for initial treatment of depressive episodes? Pro].

Authors:  T Bschor
Journal:  Nervenarzt       Date:  2016-05       Impact factor: 1.214

Review 2.  Chronic and treatment resistant depression: diagnosis and stepwise therapy.

Authors:  Tom Bschor; Michael Bauer; Mazda Adli
Journal:  Dtsch Arztebl Int       Date:  2014-11-07       Impact factor: 5.594

3.  Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study.

Authors:  Vera M Ludwig; Cathrin Sauer; Allan H Young; James Rucker; Michael Bauer; Hannelore Findeis; Philipp Ritter
Journal:  CNS Drugs       Date:  2021-07-20       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.